|
1.
|
Hwang HJ, Kang YJ, Hossain MA, et al:
Novel dihydrobenzofuro[4,5-b][1,8]naphthyridin-6-one derivative,
MHY-449, induces apoptosis and cell cycle arrest in HCT116 human
colon cancer cells. Int J Oncol. 41:2057–2064. 2012.
|
|
2.
|
National Cancer Information Center: Cancer
incidence and death. Goyang . http://www.cancer.go.kr/mbs/cancer.
Accessed July 21, 2013.
|
|
3.
|
Kelly C and Cassidy J: Chemotherapy in
metastatic colorectal cancer. Surg Oncol. 16:65–70. 2007.
View Article : Google Scholar
|
|
4.
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar
|
|
5.
|
Sun SY, Hail N Jr and Lotan R: Apoptosis
as a novel target for cancer chemoprevention. J Natl Cancer Inst.
96:662–672. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Aggarwal BB and Shishodia S: Suppression
of the nuclear factor-kappaB activation pathway by spice-derived
phytochemicals: reasoning for seasoning. Ann NY Acad Sci.
1030:434–441. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Horst D, Budczies J, Brabletz T, Kirchner
T and Hlubek F: Invasion associated up-regulation of nuclear factor
kappaB target genes in colorectal cancer. Cancer. 115:4946–4958.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Luo JL, Maeda S, Hsu LC, Yagita H and
Karin M: Inhibition of NF-kappaB in cancer cells converts
inflammation-induced tumor growth mediated by TNFalpha to
TRAIL-mediated tumor regression. Cancer Cell. 6:297–305. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Nandy P, Lien EJ and Avramis VI:
Inhibition of ribonucleotide reductase by a new class of isoindole
derivatives: drug synergism with cytarabine (Ara-C) and induction
of cellular apoptosis. Anticancer Res. 19:1625–1633.
1999.PubMed/NCBI
|
|
10.
|
Choudhary C, Kumar C, Gnad F, et al:
Lysine acetylation targets protein complexes and co-regulates major
cellular functions. Science. 325:834–840. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Walkinshaw DR and Yang XJ: Histone
deacetylase inhibitors as novel anticancer therapeutics. Curr
Oncol. 15:237–243. 2008.PubMed/NCBI
|
|
12.
|
Mottet D and Castronovo V: Histone
deacetylases: target enzymes for cancer therapy. Clin Exp
Metastasis. 25:183–189. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Jeon HS, Ahn MY, Park JH, et al:
Anticancer effects of the MHY218 novel hydroxamic acid-derived
histone deacetylase inhibitor in human ovarian cancer cells. Int J
Oncol. 37:419–428. 2010.PubMed/NCBI
|
|
14.
|
Park JH, Ahn MY, Kim TH, et al: A new
synthetic HDAC inhibitor, MHY218, induces apoptosis or
autophagy-related cell death in tamoxifen-resistant MCF-7 breast
cancer cells. Invest New Drugs. 30:1887–1898. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Molinari M: Cell cycle checkpoints and
their inactivation in human cancer. Cell Prolif. 33:261–274. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Niculescu AB 3rd, Chen X, Smeets M, Hengst
L, Prives C and Reed SI: Effects of p21(Cip1/Waf1) at both the G1/S
and the G2/M cell cycle transitions: pRb is a critical determinant
in blocking DNA replication and in preventing endoreduplication.
Mol Cell Biol. 18:629–643. 1998.PubMed/NCBI
|
|
17.
|
Baus F, Gire V, Fisher D, Piette J and
Dulic V: Permanent cell cycle exit in G2 phase after DNA damage in
normal human fibroblasts. EMBO J. 22:3992–4002. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
el-Deiry WS, Tokino T, Velculescu VE, et
al: WAF1, a potential mediator of p53 tumor suppression. Cell.
75:817–825. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Gartel AL and Tyner AL: Transcriptional
regulation of the p21((WAF1/CIP1)) gene. Exp Cell Res. 246:280–289.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Iannolo G, Conticello C, Memeo L and De
Maria R: Apoptosis in normal and cancer stem cells. Crit Rev Oncol
Hematol. 66:42–51. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Lorenzo HK and Susin SA: Therapeutic
potential of AIF-mediated caspase-independent programmed cell
death. Drug Resist Updat. 10:235–255. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Guo B, Godzik A and Reed JC: Bcl-G, a
novel pro-apoptotic member of the Bcl-2 family. J Biol Chem.
276:2780–2785. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Harris MH and Thompson CB: The role of the
Bcl-2 family in the regulation of outer mitochondrial membrane
permeability. Cell Death Differ. 7:1182–1191. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Lahiry L, Saha B, Chakraborty J, et al:
Theaflavins target Fas/caspase-8 and Akt/pBad pathways to induce
apoptosis in p53-mutated human breast cancer cells. Carcinogenesis.
31:259–268. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Kopp E and Ghosh S: Inhibition of NF-kappa
B by sodium salicylate and aspirin. Science. 265:956–959. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Spehlmann ME and Eckmann L: Nuclear
factor-kappa B in intestinal protection and destruction. Curr Opin
Gastroenterol. 25:92–99. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Bond M, Fabunmi RP, Baker AH and Newby AC:
Synergistic upregulation of metalloproteinase-9 by growth factors
and inflammatory cytokines: an absolute requirement for
transcription factor NF-kappa B. FEBS Lett. 435:29–34. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Chopra A, Ferreira-Alves DL, Sirois P and
Thirion JP: Cloning of the guinea pig 5-lipoxygenase gene and
nucleotide sequence of its promoter. Biochem Biophys Res Commun.
185:489–495. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
29.
|
Nagaki M, Naiki T, Brenner DA, et al:
Tumor necrosis factor alpha prevents tumor necrosis factor
receptor-mediated mouse hepatocyte apoptosis, but not fas-mediated
apoptosis: role of nuclear factor-kappaB. Hepatology. 32:1272–1279.
2000. View Article : Google Scholar
|
|
30.
|
Wajant H, Pfizenmaier K and Scheurich P:
Tumor necrosis factor signaling. Cell Death Differ. 10:45–65. 2003.
View Article : Google Scholar
|
|
31.
|
Mann JR and DuBois RN: Cyclooxygenase-2
and gastrointestinal cancer. Cancer J. 10:145–152. 2004. View Article : Google Scholar
|
|
32.
|
Kim JH, Lee KW, Lee MW, Lee HJ, Kim SH and
Surh YJ: Hirsutenone inhibits phorbol ester-induced upregulation of
COX-2 and MMP-9 in cultured human mammary epithelial cells:
NF-kappaB as a potential molecular target. FEBS Lett. 580:385–392.
2006. View Article : Google Scholar
|
|
33.
|
Claria J and Romano M: Pharmacological
intervention of cyclooxygenase-2 and 5-lipoxygenase pathways.
Impact on inflammation and cancer. Curr Pharm Des. 11:3431–3447.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Surh YJ, Chun KS, Cha HH, et al: Molecular
mechanisms underlying chemopreventive activities of
anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS
through suppression of NF-kappa B activation. Mutat Res.
480–481:243–268. 2001.
|
